Study guide
8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia)
Neonatal Pediatric Transport C-NPT
Track your progress as you read
Finished sections get a check mark.
1 Introduction: The C-NPT Exam
About the C-NPT Exam: 2026 Format, Eligibility & Content Outline
2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues
1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations
3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment
2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning
4 Chapter 3: Flight Physiology & Environmental Stressors
3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit
5 Chapter 4: Invasive Procedures & Transport Monitoring
4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines
6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation
5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting
7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes
6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies
8 Chapter 7: Neonatal Respiratory Pathologies & Management
7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure
9 Chapter 8: Neonatal Cardiovascular Critical Care
8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure
10 Chapter 9: Neonatal Neurological & Metabolic Crises
9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)
11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care
10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect
12 Chapter 11: Pediatric Respiratory Emergencies
11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia
13 Chapter 12: Pediatric Shock & Cardiovascular Crises
12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass
14 Chapter 13: Pediatric Neurological Emergencies & Trauma
13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness
15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies
14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures
16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies
15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises
8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia)
Key Takeaways Explain This Topic AI
Ductal-dependent cyanotic congenital heart defects (CHDs) require right-to-left or left-to-right shunting across the ductus arteriosus to sustain pulmonary perfusion or permit essential intercirculatory mixing.
The Hyperoxia Test distinguishes cyanotic CHD from primary parenchymal pulmonary failure: exposing the neonate to 100% FiO2 for 10 minutes yields a PaO2 <100–150 mmHg in fixed anatomical intracardiac shunts, whereas parenchymal lung disease typically achieves a PaO2 >150–200 mmHg.
Transposition of the Great Arteries (TGA) creates complete parallel circuits where survival mandates bidirectional mixing across a PFO, ASD, VSD, or PDA; restrictive interatrial communication refractory to PGE1 demands emergent balloon atrial septostomy (Rashkind procedure).
Acute hypercyanotic 'Tet spells' in Tetralogy of Fallot stem from infundibular right ventricular outflow tract spasm; immediate management focuses on knee-chest positioning to elevate SVR, fluid boluses (10 mL/kg) to expand RV filling, morphine (0.05–0.1 mg/kg) to blunt adrenergic drive, and phenylephrine (5–20 mcg/kg) to reverse the right-to-left VSD shunt.
Prostaglandin E1 (alprostadil) infusion (0.01–0.1 mcg/kg/min) is life-saving for maintaining ductal patency, but transport crews must anticipate drug-induced apnea (occurring in 10%–12% of neonates), profound vasodilation, hypotension, and hyperthermia, ensuring proactive airway readiness.
Last updated: September 2026
Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia)
Critical cyanotic congenital heart defects (CCHD) in the neonate require rapid diagnostic discrimination, advanced hemodynamic stabilization, and decisive transport interventions. In ductal-dependent pulmonary blood flow and parallel mixing lesions, survival depends upon maintaining an open ductus arteriosus (PDA) or obligatory intracardiac shunts.
Differentiating Cyanotic CHD from Respiratory Failure: The Hyperoxia Test
At birth, the drop in pulmonary vascular resistance (PVR) and cord clamping establish neonatal circulation. When a cyanotic newborn fails to respond to oxygen, clinicians must rapidly distinguish primary pulmonary disease from structural heart defects using the Hyperoxia Test :
Protocol: Place the infant on 100 % FiO 2 100\%\text{ FiO}_2 100% FiO 2 via an oxy-hood or endotracheal tube for 10 to 15 minutes. Obtain an arterial blood gas (ABG) from the right radial artery (preductal).
Parenchymal Pulmonary Disease: Nitrogen washout maximizes alveolar oxygen tension. In respiratory distress syndrome, meconium aspiration, or transient tachypnea, high alveolar P O 2 PO_2 P O 2 overcomes ventilation-perfusion ( V / Q V/Q V / Q ) mismatch, driving arterial P a O 2 PaO_2 P a O 2 to >150–200 mmHg (frequently >300 mmHg).
Cyanotic Congenital Heart Disease: Fixed anatomical right-to-left shunts or parallel circuits cause unoxygenated systemic venous blood to bypass alveolar gas exchange entirely. Arterial P a O 2 PaO_2 P a O 2 remains <100–150 mmHg (often <50–70 mmHg) despite 100 % FiO 2 100\%\text{ FiO}_2 100% FiO 2 .
PPHN Distinction: Severe persistent pulmonary hypertension of the neonate causes massive extrapulmonary right-to-left shunting through the PFO and PDA, mimicking cyanotic CHD. Comparing simultaneous preductal (right radial) and postductal (umbilical artery or lower extremity) gases reveals a P a O 2 PaO_2 P a O 2 gradient >15–20 mmHg (or S p O 2 SpO_2 Sp O 2 difference >5%–10%).
Transposition of the Great Arteries (TGA)
In dextro-Transposition of the Great Arteries (d-TGA), ventriculoarterial discordance creates two independent parallel circuits: the aorta arises from the morphological right ventricle, recirculating deoxygenated venous blood to the body, while the pulmonary artery arises from the left ventricle, returning oxygenated blood to the lungs.
Intercirculatory Mixing: Extrauterine survival requires bidirectional mixing across a patent foramen ovale (PFO), atrial septal defect (ASD), ventricular septal defect (VSD), or PDA. Neonates present with severe cyanosis ( S p O 2 SpO_2 Sp O 2 50%–70%) within hours of life, displaying "happy tachypnea" without significant respiratory distress. Chest radiography displays an "egg-on-a-string" appearance due to great artery alignment and thymic involution.
Medical Stabilization & Rashkind Septostomy: Continuous infusion of Prostaglandin E1 (Alprostadil) at 0.05–0.1 mcg/kg/min maintains ductal patency. If the interatrial communication is restrictive, mixing remains inadequate despite a patent PDA, causing intractable hypoxemia ( P a O 2 < 25 mmHg PaO_2 <25\text{ mmHg} P a O 2 < 25 mmHg ) and pulmonary venous hypertension. This hyperacute emergency requires an immediate bedside balloon atrial septostomy (Rashkind procedure) to tear the septum primum and establish unrestrictive interatrial mixing.
Tetralogy of Fallot (TOF) & Hypercyanotic "Tet" Spells
Tetralogy of Fallot comprises four anatomical anomalies resulting from anterocephalad deviation of the infundibular septum:
- Right ventricular outflow tract obstruction (RVOTO; infundibular and/or pulmonary valve stenosis)
- Malalignment ventricular septal defect (VSD)
- Overriding aorta
- Right ventricular hypertrophy (RVH), creating a "boot-shaped heart" ( coeur en sabot ) on radiograph
- Pathophysiology & Management of "Tet Spells"
A hypercyanotic spell is an acute paroxysm of profound hypoxemia, hyperpnea, and limpness caused by muscular spasm of the subpulmonary infundibulum. Triggered by crying, agitation, or dehydration, infundibular contraction sharply increases RVOTO resistance while peripheral vasodilation drops systemic vascular resistance (SVR). Blood diverts right-to-left across the VSD into the aorta; the harsh systolic murmur disappears as pulmonary blood flow ceases.
Clinical Protocol: Hypercyanotic Spell Transport Algorithm
Knee-Chest Position: Flex hips and knees firmly against the chest. Kinking the femoral arteries abruptly increases SVR, opposing the VSD right-to-left shunt and redirecting blood into the pulmonary artery.
Calm the Infant: Swaddle and minimize noxious stimulation to curb catecholamine surges.
High-Flow Oxygen: Delivers pulmonary vasodilation and mild systemic vasoconstriction.
Isotonic Fluid Bolus (10 mL/kg): Rapid crystalloid expansion increases RV end-diastolic volume, mechanically widening the infundibular outflow tract.
Morphine Sulfate (0.05–0.1 mg/kg IV/IM): Suppresses the tachypneic respiratory drive and breaks the adrenergic feedback loop.
Beta-Blockade (Propranolol 0.05–0.1 mg/kg IV or Esmolol): Directly relaxes spastic infundibular myocardium.
Phenylephrine (5–20 mcg/kg IV bolus or 0.1–0.5 mcg/kg/min): Pure alpha-1 agonist that markedly elevates SVR, reversing right-to-left shunting.
Tricuspid Atresia & Pulmonary Atresia with Intact Septum
In Tricuspid Atresia , agenesis of the tricuspid valve forces systemic venous blood across an obligate right-to-left atrial shunt (PFO/ASD) into the left heart. In Pulmonary Atresia with Intact Ventricular Septum (PA-IVS) , complete pulmonary valve obstruction creates a diminutive, hypertensive right ventricle with zero forward pulmonary flow. In both lesions, pulmonary circulation relies entirely upon retrograde flow across a PDA. Functional ductal closure causes lethal hypoxemia, metabolic acidosis, and death, mandating immediate PGE1 therapy.
Prostaglandin E1 Management & Transport Considerations
Synthetic PGE1 (Alprostadil) relaxes ductal smooth muscle via elevated intracellular cAMP:
Dosing: Initiate at 0.01–0.1 mcg/kg/min (starting at 0.05–0.1 mcg/kg/min; titrate down to 0.01–0.025 mcg/kg/min once the ductus is patent).
Transport Hazards: PGE1 induces apnea in 10%–12% of neonates , typically within 60 minutes. Airway equipment must be immediately accessible, with elective intubation strongly considered for flight. Other side effects include hypotension, peripheral flushing, pyrexia, and seizure-like twitching.
Comparison of Ductal-Dependent Cyanotic Lesions
Lesion Anatomical Defect Chest Radiograph Primary Intercirculatory Dependency Critical Transport Interventions
d-TGA Parallel circuits (RV → \rightarrow → Aorta; LV → \rightarrow → PA) "Egg-on-a-string" (narrow superior mediastinum) Bidirectional mixing (ASD/PFO, PDA, VSD) PGE1 infusion; emergency Rashkind septostomy if restrictive PFO
TOF RVOTO, VSD, overriding aorta, RVH "Boot-shaped heart" (upturned apex) SVR vs PVR balance; PDA if severe stenosis Knee-chest positioning, volume bolus (10 mL/kg), morphine, phenylephrine
Tricuspid Atresia Imperforate tricuspid valve, hypoplastic RV Decreased pulmonary vascular markings Obligate ASD (R-to-L); PDA for pulmonary flow Continuous PGE1 infusion; avoid high FiO2 to prevent steal
PA-IVS Imperforate pulmonary valve, intact septum Diminished pulmonary blood flow Obligate ASD (R-to-L); 100% ductal pulmonary flow Continuous PGE1 infusion; proactive airway management for apnea
Realistic Transport Scenario: Hypercyanotic Spell During Air Transport
A transport team is transferring a 6-week-old infant (weight 4.2 kg) with unrepaired Tetralogy of Fallot via fixed-wing aircraft. During climb-out, the infant cries vigorously, becomes profoundly cyanotic, and desaturates from 82% to 42% with heart rate 195 bpm. The transport nurse immediately places the infant in a tight knee-chest position while the respiratory therapist applies 100% FiO2. An isotonic crystalloid bolus of 40 mL (10 mL/kg) is rapidly infused, and 0.3 mg morphine sulfate IV is administered. Within 4 minutes, the infant calms, the systolic ejection murmur reappears, and SpO2 stabilizes at 85%, successfully aborting the spell without endotracheal intubation.
Clinical Pearls for Cyanotic Neonatal Heart Defects
Important
The Hyperoxia Test Threshold: A PaO2 <100–150 mmHg on 100% FiO2 confirms fixed right-to-left intracardiac shunting or parallel circulation, ruling out uncomplicated parenchymal pulmonary disease.
Tip
Tet Spell Hemodynamics: In a hypercyanotic spell, knee-chest positioning increases SVR immediately; phenylephrine provides pure alpha-1 vasoconstriction to force blood from the right ventricle across the pulmonary valve.
Note
PGE1 Apnea Window: Prostaglandin E1 induces sudden apnea in up to 12% of newborns within the first hour of initiation. Always ensure immediate airway readiness prior to transport departure.